Prenatal Screening for Down Syndrome: New Developments for Biochemical And Ultrasound Markers

April 4, 2006: Nathalie Lepage, PhD

Prenatal screening for Down syndrome continues to change with the addition of new markers, biochemical and sonographic; and screening windows, first and/or second trimester. Information from these markers is available for risk prediction of fetal outcome. This presentation will present the major options, the quality management and the expected development in the upcoming years.

Page Access: